Machatha Stephen 4
4 · Aldeyra Therapeutics, Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Machatha Stephen
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2025-03-04+202,427→ 202,427 totalExercise: $6.17Exp: 2035-03-03→ Common Stock (202,427 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2025.